How far advanced the application of NGS technology to head and neck cancer?

Abstract

In Japan, cancer genome medicine started in 2018. The term “next-generation sequencer （NGS）,” which is the core component of this technology, is expected to become increasingly widespread. This paper illustrates what NGS is, what can be done using NGS, and how to use NGS to solve issues through plain images. In addition, strategies to identify the Achilles’ heel of cancer using NGS in combination with other advancing technologies is discussed through examples of head and neck cancer research.